1. High-throughput screening of functional neo-antigens and their specific TCRs via the Jurkat reporter system combined with droplet microfluidics
- Author
-
Yijian Li, Jingyu Qi, Yang Liu, Yuyu Zheng, Haibin Zhu, Yupeng Zang, Xiangyu Guan, Sichong Xie, Hongyan Zhao, Yunyun Fu, Haitao Xiang, Weicong Zhang, Huanyi Chen, Huan Liu, Yuntong Zhao, Yu Feng, Fanyu Bu, Yanling Liang, Yang Li, Qumiao Xu, Ying He, Li Sun, Longqi Liu, Ying Gu, Xun Xu, Yong Hou, Xuan Dong, and Ya Liu
- Abstract
SummaryT-cell receptor (TCR)-engineered T cells can precisely recognize a broad repertoire of targets derived from both intracellular and surface proteins of tumor cells. TCR-T adoptive cell therapy has shown safety and promising efficacy in solid tumor immunotherapy. However, antigen-specific functional TCR screening is time-consuming and expensive, which limits its application clinically. Here, we developed a novel integrated antigen-TCR screening platform based on droplet microfluidics technology, enabling high-throughput peptide-major histocompatibility complex (pMHC) library-to-TCR library screening with high sensitivity and low background signal. We introduced DNA barcoding technology to label peptide antigen candidate-loaded antigen-presenting cells (APCs) and Jurkat reporter cells to check the specificity of pMHC-TCR candidates. Coupled with the next-generation sequencing pipeline, interpretation of the DNA barcodes and the gene expression level of the Jurkat T-cell activation pathway provided a clear peptide-MHC-TCR recognition relationship. Our proof-of-principle study demonstrates that the platform could achieve unbiased pMHC-TCR library-on-library screening, which is expected to be used in the cross-reactivity and off-target testing of candidate pMHC-TCR libraries in clinical applications.
- Published
- 2023